Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: Studies ofCDKN2A and other genes of the pRB pathway

1 Oct 1999

Abstract excerpt

Malignant peripheral nerve sheath tumors (MPNSTs) are frequently associated with the disease neurofibromatosis type 1. Only few recurrent cytogenetic changes have been reported, including rearrangements of the short arm of chromosome 9. By fluorescence in situ hybridization with a centromere 9 probe, and by allelic imbalance studies with seven 9p21-23 markers in nine familial and three sporadic MPNSTs, we found...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Neurofibromatosis and Schwannoma Cases
Share to Sarcoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10469453
DOI: 10.1002/(sici)1098-2264(199910)26:2<151::aid-gcc7>3.0.co;2-a

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: Studies ofCDKN2A and other genes of the pRB pathwayPMID 10469453Read ↗

Loss of p16 (INK4A) expression is associated with allelic imbalance/loss of heterozygosity of chromosome 9p21 in microdissected malignant peripheral nerve sheath tumors.Semantic proximity Read ↗

DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGHSemantic proximity Read ↗

Genomic Changes in Chromosomes 10, 16, and X in Malignant Peripheral Nerve Sheath Tumors Identify a High-Risk Patient GroupSemantic proximity Read ↗

Chromosomal translocations inactivating CDKN2A support a single path for malignant peripheral nerve sheath tumor initiation.Semantic proximity Read ↗

Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysisSemantic proximity Read ↗

Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic studySemantic proximity Read ↗

The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesotheliomaSemantic proximity Read ↗

Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.Semantic proximity Read ↗

Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.Semantic proximity Read ↗

Frequent Loss of 9p21 (p16INK4A) and Other Genomic Imbalances in Human Malignant Fibrous HistiocytomaSemantic proximity Read ↗

Biallelic inactivation ofTP53 rarely contributes to the development of malignant peripheral nerve sheath tumorsSemantic proximity Read ↗

High-resolution analysis of 9p loss in human cancer cells using single nucleotide polymorphism-based mapping arrays.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.